HOME › DRUGS › INSULIN LISPRO RECOMBINANT
ACTIVE SUBSTANCE / INN

INSULIN LISPRO RECOMBINANT

Brand name(s): HUMALOG KWIKPEN, HUMALOG PEN, HUMALOG TEMPO PEN, HUMALOG MIX 75/25 PEN, HUMALOG, HUMALOG MIX 50/50 PEN, HUMALOG MIX 50/50 KWIKPEN, HUMALOG MIX 50/50, HUMALOG MIX 75/25 KWIKPEN, HUMALOG MIX 75/25
FDA LISTED
PRESCRIPTION
DISCONTINUED
BLA205747
BLA021017
ACTIVE SUBSTANCE
Insulin Lispro Recombinant
REGULATORS
FDA
SPONSORS / MAH
LILLY, ELI LILLY AND CO
TOTAL APPLICATIONS
10
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
HUMALOG MIX 75/25 PENBLA021017LILLYDiscontinued
HUMALOG MIX 75/25BLA021017LILLYPrescription
HUMALOG MIX 75/25 KWIKPENBLA021017LILLYPrescription
HUMALOG KWIKPENBLA205747ELI LILLY AND COPrescription
HUMALOG PENBLA020563LILLYDiscontinued
HUMALOG TEMPO PENBLA020563LILLYPrescription
HUMALOGBLA020563LILLYPrescription
HUMALOG MIX 50/50 KWIKPENBLA021018LILLYPrescription
HUMALOG MIX 50/50 PENBLA021018LILLYDiscontinued
HUMALOG MIX 50/50BLA021018LILLYPrescription

FULL INTELLIGENCE ON INSULIN LISPRO RECOMBINANT

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →